Enlivex Ltd. current report, Q3 FY2026

Business Context and Reporting Period

Enlivex Ltd. filed this Form 6-K on September 29, 2026, reporting that it will hold an Extraordinary General Meeting of Shareholders on October 14, 2026, at 10:00 a.m. Israel time, at its offices in Nes Ziona, Israel. The company is an Israeli foreign private issuer that files annual reports on Form 20-F.

Financial Results and Material Changes

This filing reports no revenue, profit, cash flow, margin, debt, liquidity, or other financial results. It provides no comparable-period data or financial guidance.

Meeting Materials, Outlook, and Risks

The notice and proxy statement (Exhibit 99.1) and form of proxy card (Exhibit 99.2) are identified as accompanying exhibits and incorporated by reference. Their contents, including the meeting agenda, are not included in the supplied filing text. The filing states that its information, including the exhibits, is incorporated by reference into specified SEC registration statements.

Key Facts to Verify

  • Review the full proxy statement and notice for the meeting agenda, proposed resolutions, and any associated risks or contingencies.
  • Confirm the meeting logistics and any deadlines or voting procedures in the proxy materials.
  • Consult the company’s financial filings for current financial condition and performance; this 6-K provides no financial metrics.